CLINICAL_TRIALS
withdrawal
· 2022-11-03
Clinical Trial Update: Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs [Phase 3]
Summary
A Phase 3 trial comparing two pancreatic enzyme drugs in patients with pancreatic insufficiency has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Azidus Brasil | Conditions: Chronic Renal Failure | Phase 3 | Status: WITHDRAWN